ライフサイエンスコーパス: oropharynx

1 d and in episodic shedding of virus from the oropharynx.

2 ly impaired in ability to colonize the mouse oropharynx.

3 aired in their ability to colonize the mouse oropharynx.

4 irus to persist in, and to be shed from, the oropharynx.

5 genes and whether MalR helps GAS infect the oropharynx.

6 contributes to the persistence of GAS in the oropharynx.

7 jor breakdown product of starch in the human oropharynx.

8 the lingual and palatine tonsils within the oropharynx.

9 erapy (63-76.8 Gy) for primary tumors of the oropharynx.

10 he ability of GAS to successfully infect the oropharynx.

11 ly cleared virus from blood but not from the oropharynx.

12 d to collect secretions from the trachea and oropharynx.

13 erior nasopharynx or orally to the posterior oropharynx.

14 ransmission of strains between the blood and oropharynx.

15 rostral oropharynx, velopharynx, and caudal oropharynx.

16 Similar effects occurred in the caudal oropharynx.

17 uman serum albumin (HSA) administered to the oropharynx.

18 patients with cancers of the oral tongue and oropharynx.

19 oropharynx, and retrieving the ends from the oropharynx.

20 uamous cell carcinoma of the oral cavity and oropharynx.

21 n, persistence, and tumor development in the oropharynx.

22 the core of mucosal immune responses in the oropharynx.

23 s limited to treating distal oral mucosa and oropharynx.

24 especially from extragenital sites like the oropharynx.

25 primarily HPV16) with cancers arising in the oropharynx.

26 % unculturable virus was 60 days in skin and oropharynx.

27 with primary squamous cell carcinoma of the oropharynx.

28 nd increased abundance of Pasteurella in the oropharynx.

29 who presented with discharging sinus in the oropharynx.

30 ated with patient outcome for cancers of the oropharynx.

31 P HNSCCs were found in sites adjacent to the oropharynx.

32 ine tongue base and food bolus back into the oropharynx.

33 malignancies of the vulva, vagina, anus, and oropharynx.

34 ns and/or less microbial colonization of the oropharynx.

35 notable for minor swelling of the posterior oropharynx.

36 ated with patient outcome for cancers of the oropharynx.

37 showed an extension into the nasal cavity or oropharynx.

38 ere HPV infection is less common than in the oropharynx.

39 seudomonas aeruginosa was instilled into the oropharynx.

40 the cervix, vulva, vagina, anus, penis, and oropharynx.

41 imens or collection devices pass through the oropharynx.

42 rus whose primary site of replication is the oropharynx.

43 atent syphilis (5/86 peripheral blood, 21/86 oropharynx, 11/86 ano-rectum, and 6/86 urine).

44 rimary syphilis (2/70 peripheral blood, 7/70 oropharynx, 13/70 ano-rectum, and 24/70 urine); in 62/73

45 Primary sites were oropharynx (164 [53.2%]; 164 [84.7%] were human papillom

46 ral cavity (24 [73%]), larynx (7 [21%]), and oropharynx (2 [6%]).

47 The most common treatment site was oropharynx (268 [46.5%]), and most patients received con

48 dary syphilis (15/73 peripheral blood, 47/73 oropharynx, 37/73 ano-rectum, and 26/73 urine); and in 2

49 Oropharynx (40%) and oral cavity (27%) were the predomin

50 dvanced HNC with mostly cancers being of the oropharynx (42.2%), oral cavity (17%), and larynx (16.3%

51 .8%, and blue food coloring was found in the oropharynx 5.1% of the time.

52 s (41 concurrent and 39 sequential) were 71% oropharynx (53% HPV+), 92.5% stage IV (46% T4, 76% N2),

53 562 patients were included (397 oropharynx, 53 hypopharynx, 48 larynx, 64 other/unknown

54 Primary tumor sites included the oropharynx (99 [46.7%]), oral cavity (61 [28.8%]), and l

55 ived from an upwards growth of the primitive oropharynx, a K5-expressing tissue.

56 from the nasopharynx (all participants) and oropharynx (adults only) were collected and tested by en

57 In the rostral oropharynx, airway area increased with individual and co

58 s of the oral tongue, other oral cavity, and oropharynx among the US elderly individuals (age 65 year

59 oropharynx (p16+ OPSCC) and (2) p16-negative oropharynx and all other subsites regardless of p16 stat

60 are the etiological agents of cancers of the oropharynx and anogenital tract.

61 amples, but these viruses are present in the oropharynx and are shed in saliva.

62 ted birds shed virus at high titers from the oropharynx and cloaca, and infection was fatal.

63 dentification of premalignant lesions in the oropharynx and discuss potential biomarkers for orophary

64 case of neuroglial choristoma centred in the oropharynx and extending into the parapharyngeal space t

65 model that can be utilized to study mucosal (oropharynx and gastrointestinal [GI]) colonization, shed

66 genic bacteria or commensal organisms of the oropharynx and genital tract, (iii) a 95% probability of

67 A streptococcus (GAS) commonly colonizes the oropharynx and nonintact skin.

68 of cancers in the larynx (21.8%, 20.5-23.1), oropharynx and oral cavity (19.5%, 18.7-20.3), and bladd

69 to diverse communities of microbes from the oropharynx and other sources, and over the past decade,

70 a gram-negative anaerobe that resides in the oropharynx and possesses numerous virulence factors that

71 (aerobic Gram-bacilli except E. coli) in the oropharynx and rectum.

72 data suggest that KSHV can replicate in the oropharynx and that salivary contact could contribute to

73 he endodermal epithelial cells that line the oropharynx and the adjacent mesenchyme that is derived f

74 tain outside a virtual cavity connecting the oropharynx and the back of the mouth, which prevents foo

75 f polymyxin/tobramycin/amphotericin B in the oropharynx and the gastric tube plus a mupirocin/chlorhe

76 omas (HNCs), especially those arising in the oropharynx and the tonsils.

77 x (floor of mouth; gum and other mouth; lip; oropharynx and tonsil; and tongue) and larynx were ident

78 is a small secreted protein expressed in the oropharynx and upper airways of humans, mice, rats, and

79 is usually caused by organisms living in the oropharynx and upper airways.

80 nfectious pathogens that commonly infect the oropharynx and uterine cervix.

81 than anteroposterior dimension in the caudal oropharynx and velopharynx, especially as airway cross-s

82 at the higher pressure ranges in the caudal oropharynx and velopharynx.

83 responses of two squamous carcinomas, SCC-9 (oropharynx) and HEP-2 (larynx), were examined to determi

84 57 years, 92% had stage 4 disease, 71% were oropharynx, and 100% had a performance status of 0.

85 man cancers, such as those in the esophagus, oropharynx, and colon.

86 Motion of the nasopharynx, oropharynx, and hypopharynx was characterized as static

87 The nasopharynx, oropharynx, and hypopharynx were characterized in terms

88 yed for S. aureus colonization of the nares, oropharynx, and inguinal region and risk factors for S.

89 t of head and neck cancers, primarily in the oropharynx, and is largely responsible for the rising wo

90 squamous cell carcinoma of the oral cavity, oropharynx, and larynx or hypopharynx.

91 diverse cancers arising in the oral cavity, oropharynx, and larynx, with the main risk factors being

92 ding the anterior and posterior nasopharynx, oropharynx, and nares.

93 the most to least prevalent are the larynx, oropharynx, and nasopharynx.

94 ied epithelium of the skin, lung, esophagus, oropharynx, and other tissues.

95 n microorganisms normally found in the human oropharynx, and Pal-resistant pneumococci could not be d

96 te, salivary glands, tongue, floor of mouth, oropharynx, and periodontium.

97 rs of age that had all three sources (urine, oropharynx, and rectum) collected at the same visit.

98 the catheter through the nostrils, into the oropharynx, and retrieving the ends from the oropharynx.

99 icrobial samples (obtained from nasopharynx, oropharynx, and saliva; 80 from each site) was tested.

100 sh volume, presence of blue food coloring in oropharynx, and stool frequency were recorded every 4 hr

101 the first site of CWD prion entry is in the oropharynx, and the initial phase of prion amplification

102 e measured in the rostral oropharynx, caudal oropharynx, and velopharynx with and without bilateral s

103 cers include squamous cell carcinomas of the oropharynx, anus, vulva, vagina or penis, or cervical ca

104 The rectum and oropharynx are important anatomic sites of infection and

105 and the role of transmission to and from the oropharynx, are needed to inform prevention planning.

106 To evaluate the posterior oropharynx as a source of HIV shedding, we studied 64 HI

107 e II transport cycles (food transport to the oropharynx before swallowing).

108 and carcinomas in the anogenital region and oropharynx between 1990 and 2015 were extracted.

109 vation reduced GAS colonization of the mouse oropharynx but did not detrimentally affect invasive inf

110 ast, unopposed tongue protrusion dilates the oropharynx, but has a minimal effect on pharyngeal airwa

111 reptococcus (GAS) commonly infects the human oropharynx, but the initial molecular events governing t

112 diverse microbiome that originates from the oropharynx by a mechanism of micro-aspiration.

113 ection, aphthous ulceration of the mouth and oropharynx can become extensive and debilitating.

114 ia meningitidis a commensal bacterium of the oropharynx can cause meningitis, a disease with epidemic

115 Human papillomavirus-associated oropharynx cancer (HPVA-OPC) is rapidly increasing in in

116 ated with a future diagnosis of HPV-positive oropharynx cancer (HPVOPC).

117 a large contemporary cohort of patients with oropharynx cancer (OPC) and address limitations of the p

118 e for human papillomavirus-associated (HPV+) oropharynx cancer (OPC) but induces significant toxicity

119 ent in human papillomavirus (HPV)-associated oropharynx cancer (OPC) enrolled patients with resectabl

120 Oropharynx cancer (OPC) incidence has increased for seve

121 ts with human papillomavirus (HPV) -positive oropharynx cancer (OPC) relative to HPV-negative OPC, bu

122 ent personalisation remains an unmet need in oropharynx cancer (OPC).

123 study, readmission rates following TORS for oropharynx cancer decreased over time; however, a subset

124 It is unknown how the trajectory of the oropharynx cancer epidemic may be changing in the United

125 ith tobacco use, human papillomavirus (HPV+) oropharynx cancer has in recent years emerged as the fas

126 mation, we investigated whether increases in oropharynx cancer have continued into recent birth cohor

127 Human papillomavirus-positive oropharynx cancer incidence has increased rapidly in coh

128 The exponential increase in oropharynx cancer incidence in young white US men has eb

129 Among white men, oropharynx cancer incidence increased rapidly in individ

130 utions) with locally advanced oral cavity or oropharynx cancer planned to be treated with definitive

131 study human papillomavirus (HPV)-associated oropharynx cancer separately or, at least, stratify by H

132 cross all head and neck cancer sites: HR for oropharynx cancer, 0.26; 95% CI, 0.18-0.39; for oral cav

133 ; three for oral cavity cancer and three for oropharynx cancer, and recommendations were generated fo

134 to 60% and more than 80% for HPV-associated oropharynx cancer.

135 US and Europe, 60% to 70% of newly diagnosed oropharynx cancers (a subset of head and neck cancers) a

136 In the US and Europe, 60% to 70% of incident oropharynx cancers are associated with HPV infection.

137 Before the 1990s, hypopharynx and oropharynx cancers carried the highest excess risk of SP

138 eck cancers (patients; 180 oral cancers, 135 oropharynx cancers, and 247 hypopharynx/larynx cancers)

139 For oropharynx cancers, clinical scenarios focused on hallma

140 e preferred radiosensitizer, particularly in oropharynx cancers.

141 patients with histopathologically confirmed oropharynx carcinomas on dual-source computed tomography

142 teral diameters were measured in the rostral oropharynx, caudal oropharynx, and velopharynx with and

143 nges in bacterial abundance in the feces and oropharynx correlated with lower asthmatic responses in

144 inhalation, the anatomical structure of the oropharynx creates an air curtain outside a virtual cavi

145 Persistence of C. pneumoniae in the oropharynx creates challenges for outbreak control measu

146 Used masks had either skin-dominant or oropharynx-dominant bacterial sequences, and reused mask

147 ral and transcervical ultrasonography of the oropharynx during initial clinical examination followed

148 y human epithelial cells from the epidermis, oropharynx, esophagus and cervix into genetically define

149 for adaptations of the geometry of the human oropharynx for efficient transport of food volatiles tow

150 is rectum for C. trachomatis and rectum and oropharynx for N. gonorrhoeae Hence, extragenital screen

151 imary ablative surgery of the oral cavity or oropharynx for squamous cell carcinoma in 2018 and 2019.

152 een implicated in defense of the airways and oropharynx from microbial invasion, in this proof-of-con

153 he bacterial pathogens and commensals of the oropharynx, genital tract, and rectum.

154 were enrolled and specimens from the nares, oropharynx, groin, perianal area, and wounds were prospe

155 e microbiota of 3,104 saliva (<10 year-olds)/oropharynx (>=10 year-olds) and 2,485 nasopharynx sample

156 ithelia and lymphoid germinal centers of the oropharynx have been identified as sites for FMDV persis

157 rall survival (human papillomavirus-positive oropharynx: hazard ratio [HR], 0.567 [95% CI, 0.335-0.96

158 drates are not readily available in the naso-oropharynx; however, N- and O-linked glycans are common

159 re similarly associated with survival in the oropharynx (HR for serology, 0.16; 95% CI, 0.03-0.47; fo

160 pylori and Epstein-Barr virus; n = 12 565), oropharynx (human papillomavirus; n = 12 430), and hepat

161 (HNSCCs) that can arise in the oral cavity, oropharynx, hypopharynx and larynx.

162 squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, and larynx treated with definit

163 ally advanced squamous cell carcinoma of the oropharynx, hypopharynx, larynx, or oral cavity (unselec

164 squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, or larynx undergoing first-line

165 Patients with LASCCHN of the oropharynx, hypopharynx, or larynx with measurable disea

166 nts with known carcinoma of the oral cavity, oropharynx, hypopharynx, or larynx.

167 65 years) with LA-HNSCCs of the oral cavity, oropharynx/hypopharynx, or larynx treated with definitiv

168 t that administration of surfactant into the oropharynx immediately after birth in addition to CPAP s

169 okes discussion of the potential role of the oropharynx in gonorrhoea control.

170 ent for aphthous ulceration of the mouth and oropharynx in patients with HIV infection.

171 DeltamalR strain persistently colonized the oropharynx in significantly fewer mice than the parental

172 The human oropharynx is a reservoir for many potential pathogens,

173 The oropharynx is an important asymptomatic reservoir for go

174 logy evaluations, examination of the ear and oropharynx is important but difficult to achieve remotel

175 ed in HPV-positive cancers of the cervix and oropharynx is miR-424.

176 Although the oropharynx is the primary site of infection, GAS can col

177 te smoking, causes most cancers of the lung, oropharynx, larynx, and esophagus in the USA, and approx

178 herapy for the following sites: oral tongue, oropharynx, larynx, and hypopharynx.

179 attributable mortality (cancers of the lung, oropharynx, larynx, esophagus, pancreas, kidney, bladder

180 gestive tract, specifically the oral cavity, oropharynx, larynx, hypopharynx, and paranasal sinuses,

181 with newly diagnosed SCC of the oral cavity, oropharynx, larynx, or nasopharynx was used.

182 s including malignancies of the oral cavity, oropharynx, larynx, sinuses, and skull base.

183 The normal flora of the oropharynx may be an important source of antimicrobial r

184 75%), and the most common tumor location was oropharynx (n = 32; 40%).

185 Sites included oral cavity (n = 14), oropharynx (n = 37), hypopharynx (n = 4), larynx (n = 16

186 Cqs from Nasopharynx/Oropharynx (Naso/Oro; n = 36) were similar between Biofi

187 through 2015 with HNSCC of the oral cavity, oropharynx, nasopharynx, larynx, and hypopharynx were in

188 ith highly suspected primary tumors (breast, oropharynx, nasopharynx, melanoma) that could be designa

189 as performed in which the anterior nares and oropharynx of 137 livestock veterinarians were sampled f

190 obial susceptibility profiles of Nc from the oropharynx of 50 participants.

191 of a novel commensal Neisseria sp. from the oropharynx of a patient with suspected gonococcal treatm

192 ping of the reassortant viruses shed via the oropharynx of contact chickens showed H9N2 and H9N9 as p

193 es from H9N2) was successfully shed from the oropharynx of contact chickens, plus it showed an increa

194 Commensal Neisseria (Nc) mainly occupy the oropharynx of humans and animals.

195 bacterial microbiome of the facial skin and oropharynx of individuals randomized to wearing fresh su

196 ed in skin lesions of the patient and in the oropharynx of local cats.

197 persist in human saliva and to colonize the oropharynx of mice, and seldom caused human pharyngitis.

198 vagus nerve that innervate taste buds of the oropharynx of the goldfish, Carassius auratus, project t

199 er intranasal inoculation, GAS colonized the oropharynx of wild-type mice but failed to colonize tran

200 The human oropharynx often harbors anaerobic bacteria that produce

201 and phenotypic changes in P. aeruginosa from oropharynx (OP) and bronchoalveolar lavage fluid (BALF)

202 resectable stage III/IVA and IVB larynx and oropharynx (OP) cancer patients.

203 y so, in patients with ENE- and HPV-negative oropharynx (OP), hypopharynx (HP), and larynx cancer (HR

204 includes tumours of the oral cavity (OSCC), oropharynx (OPSCC) and nasopharynx (NPC).

205 cell carcinoma of the oral cavity (OSCC) and oropharynx (OPSCC) in a large multicenter cohort, using

206 cosal lesions involving the vagina, anus, or oropharynx or eye occurred in 65 (55%) of 119 individual

207 t the initial visit for cancer affecting the oropharynx or gastrointestinal tract or advanced cancer,

208 eillance cultures were taken from the nares, oropharynx or trachea, and any open wound routinely on a

209 or IV squamous carcinoma of the oral cavity, oropharynx, or hypopharynx were eligible.

210 he head and neck (SCCHN) of the oral cavity, oropharynx, or larynx, with one or more risk factors war

211 ncident HNSCC, which includes cancers of the oropharynx, oral cavity, and larynx.

212 t, bladder, colon, esophagus, stomach, lung, oropharynx, ovary, and pancreas.

213 ersity in the nasopharynx (P = .011) but not oropharynx (P = .21).

214 een mouth position and dynamic motion in the oropharynx (P =.006) and in the nasopharynx (P <.006) bu

215 tients with stage III to IV carcinoma of the oropharynx (p16 negative), larynx, and hypopharynx with

216 with HNSCC were grouped as (1) p16-positive oropharynx (p16+ OPSCC) and (2) p16-negative oropharynx

217 othesized that anatomic abnormalities of the oropharynx, particularly narrowing of the airway by the

218 age III or IV squamous-cell carcinoma of the oropharynx, positive for HPV by p16 testing, and with Zu

219 seven previously untreated patients (41 with oropharynx primaries; 33 men, 14 women; median age, 53 y

220 an Karnofsky status, 90%; range, 70% to 90%; oropharynx primary tumor, 59% of patients; T4, 36%; N2/3

221 patients (66 with stage IV disease, 37 with oropharynx primary tumors, and 67 with performance statu

222 viding general epithelial innervation to the oropharynx project to non-gustatory hindbrain regions, i

223 tidis as they enter the bloodstream from the oropharynx protect against disseminated disease.

224 group A Streptococcus (GAS) infection of the oropharynx provokes a distinct host transcriptome respon

225 n SPM site for patients with oral cavity and oropharynx SCC was HN; for patients with laryngeal and h

226 larynx SCC compared with oral cavity SCC and oropharynx SCC.

227 age III to IV squamous cell carcinoma of the oropharynx (SCCOP) were treated with one cycle of cispla

228 and prognosis of squamous cell carcinoma of oropharynx (SCCOP).

229 HPV16-associated squamous cell carcinoma of oropharynx (SCCOP).

230 gery for human papillomavirus (HPV)-positive oropharynx squamous cell carcinoma (OPSCC) may help guid

231 Up to 10% of oropharynx squamous cell carcinomas present as squamous

232 by twice weekly monitoring of cultures from oropharynx, stools, urine, skin, and/or respiratory trac

233 es were taken from the oral cavity (saliva), oropharynx (subglottic aspirate), or lower respiratory t

234 This difference was prominent in the oropharynx subgroup.

235 ated oropharyngeal cancers, specifically the oropharynx subsite.

236 tes more aggressive tumors at HPV-associated oropharynx subsites than national averages.

237 ancers have a strong site preference for the oropharynx, suggesting the existence of unique local fac

238 demographic data) undergoing oral cavity or oropharynx surgery for squamous cell carcinoma, includin

239 Participants were offered lesion, anal, and oropharynx swabs for PCR testing.

240 Sensory inputs from the oropharynx terminate in both the trigeminal brainstem co

241 d lower levels of virus in their nasopharynx/oropharynx than symptomatic children, but the timing of

242 ominantly exists as a colonizer of the human oropharynx that occasionally breaches epithelial barrier

243 tarch and glycogen are abundant in the human oropharynx, the main site of group A Streptococcus (GAS)

244 group A Streptococcus (GAS) to colonize the oropharynx, the major site of GAS infection in humans.

245 Similarly, most sequences from oropharynx tissue clustered into two subpopulations, alb

246 from the atrophied part of the tongue in the oropharynx to the edematous part outside the mouth.

247 ving an FTP grade of I to IV, and the velum, oropharynx, tongue base, epiglottis (VOTE) classificatio

248 ction (TBR) drives the food bolus across the oropharynx towards the esophagus and flips the epiglotti

249 Daily surveillance cultures of the nares, oropharynx, trachea, and stomach demonstrated that trach

250 ultures from body sites (rectum, groin, arm, oropharynx, trachea, and stomach) and from environmental

251 Patients with p16-positive oropharynx tumors showed markedly improved survival outc

252 l treatment included non-deeply infiltrative oropharynx tumors, minimal soft palate involvement, and

253 tcome relative to patients with p16-negative oropharynx tumors.

254 trongly impact most bacterial species in the oropharynx, variation in the upper respiratory tract mic

255 s-sectional area was measured in the rostral oropharynx, velopharynx, and caudal oropharynx, with and

256 sterior and lateral diameters in the rostral oropharynx, velopharynx, and caudal oropharynx.

257 performed subgroup analyses of patients with oropharynx vs nonoropharynx primary sites.

258 cacy of topical chlorhexidine applied to the oropharynx vs. placebo or standard care for prevention o

259 Site of airway closure above or below the oropharynx was determined by measuring the respective pr

260 The oropharynx was most commonly collapsed in 98 (66%) of th

261 Clearance in the oropharynx was significantly decreased in those patients

262 The oropharynx was the most common primary tumor site both i

263 The oropharynx was the most common subsite (64 [47.1%]), mos

264 on about how GAS survives in and infects the oropharynx, we analyzed the transcriptome of a serotype

265 phagus, scant attention has been paid to the oropharynx, which is often equally affected.

266 pictures and videos of their ear canals and oropharynx with digital videoscopes and their smartphone

267 ame cage became chronically colonized in the oropharynx with environmental P. aeruginosa when the bac

268 al hypoglossus stimulation and in the caudal oropharynx with independent and combined hypoglossal bra

269 We show CWD uptake occurs in the oropharynx with initial prion replication in the drainin

270 and stimulation were present in the rostral oropharynx with medial hypoglossus stimulation and in th

271 repaired isogenic strain colonized the mouse oropharynx with significantly greater bacterial burden a

272 rostral oropharynx, velopharynx, and caudal oropharynx, with and without nerve stimulation.

273 -target effects on commensal bacteria in the oropharynx, with intimate behaviours potentially facilit

274 lerated without adverse reactions beyond the oropharynx, with no severe symptoms or uses of epinephri

275 improved visualization of the tumors of the oropharynx, without disfiguring incisions.